Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05627531 · ClinicalTrials.gov registry record · NA

Meaning Making While Your Child is in Intensive Care

A NA study, sponsored by Akron Children's Hospital.

Completed
Registry status
NA
Development phase
41
Enrollment target

NCT05627531: Completed NA study, sponsored by Akron Children's Hospital.

NCT05627531 is a NA study that has completed, run by Akron Children's Hospital. The registered enrollment target is 41 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05627531, a NA study, has completed, sponsored by Akron Children's Hospital.

COMPLETED
Registry status
NA
Development phase
41 participants
Enrollment target

Study Summary

A quarter of a million children and teenagers are hospitalized annually in Pediatric Intensive Care Units (PICUs) in North America. Having a child hospitalized in a PICU is stressful and affects the mood and coping of their parents. The investigators' prior work has shown how narrative medicine may help. Narrative medicine includes at least one session reading and then having a guided discussion of a poem or short story. The readings are individually selected by the Narrative Medicine Coordinator who also provides a guided writing exercise (in the form of poetry, creative non-fiction, journaling, or fiction). After writing, the parent/guardian had the option to share their writing out loud with the Narrative Medicine Coordinator. At the end of each session, the parent/guardian receives personalized writing prompts they are encouraged to use writing each day. The Investigators want to see how this session helps parents make sense of their time in the PICU and how it may help them cope. The investigators ask participants to fill out some surveys when they enroll and three days after their session.

Primary Outcome

The Meaning subscale of the FACIT-Sp12 is composed of items 2,3,5, and 8. The total score ranges from 0-16, with a higher score indicating more ability to attribute meaning to life. The investigators hypothesize the score to increase. The investigators follow the work of Canada and colleagues, who validated the use of a 3-factor analysis of the FACIT-SP-12 (Canada, et al. Psycho-Oncology: 2008, 908-916).

Interventions

  • BEHAVIORAL Narrative Medicine

Trial Details

FieldValue
Enrollment Target 41 participants
Start Date 2022-11-09
Est. Completion 2024-09-09
Phase NA
Akron Children's Hospital

27 total trials

What the finished NCT05627531 record still lists

NCT05627531 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 1 intervention - of which Narrative Medicine is the first listed.

NCT05627531 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05627531 about?

NCT05627531 is a clinical study titled "Meaning Making While Your Child is in Intensive Care". A quarter of a million children and teenagers are hospitalized annually in Pediatric Intensive Care Units (PICUs) in North America. Having a child hospitalized in a PICU is stressful and affects the mood and coping of their parents. The investigators' prior work has shown how narrative medicine may ...

What is the current status of trial NCT05627531?

This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2022-11-09. Estimated completion is 2024-09-09.

What interventions are being tested in trial NCT05627531?

The interventions under investigation include: Narrative Medicine (BEHAVIORAL).

Who is sponsoring clinical trial NCT05627531?

This trial is sponsored by Akron Children's Hospital, which has 27 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05627531's enrollment target sits among peer trials

41 1446th of 2000 higher than 554 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03449238 · 41 participants · Phase 1

    Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients

  • NCT03900793 · 41 participants · Phase 1

    Losartan + Sunitinib in Treatment of Osteosarcoma

  • NCT04082520 · 41 participants · Phase 2

    Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy

  • NCT04220190 · 41 participants · Phase 2

    RAPA-501 Therapy for ALS

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05627531, the US trial registry maintained by the National Library of Medicine. NCT05627531 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.